Advertisement

Drug Metabolism in Drug Development: A DIA Tutorial for Regulatory Affairs Specialists

  • Peter K. Honig
  • Louis R. Cantilena
  • Kenneth S. Santone
Article

Abstract

Many drug metabolism, drug-drug interaction, and pharmacogenetics meetings are held each year and are well attended by scientists from the pharmaceutical industry, academia, and worldwide regulatory agencies. Personal communication indicated that large amounts of drug metabolism information passed across the desks of the regulatory affairs specialists either as reports being submitted to or as information requests from regulatory agencies and that, unlike other preclinical or clinical data, there was little appreciation of the meaning or relevance of such information to the overall drug development campaign. The purpose of the tutorial described here was to allow regulatory affairs specialists to gain a working appreciation of the nomenclature, techniques, and usefulness of in vitro and in vivo drug metabolism studies.

Key Words

Metabolism Cytochrome P450 Inhibition Induction Polymorphism 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Peck CC, Temple R, Collins JM. Understanding the consequences of concurrent therapies. JAMA. 1993; 269:1150–1152.CrossRefGoogle Scholar
  2. 2.
    Monahan BP, Ferguson CL, Killeavey ES, Lloyd BK, Troy J, Cantilena LR. Torsades de pointes occurring in association with terfenadine use. JAMA. 1990;264: 2788–2790.CrossRefGoogle Scholar
  3. 3.
    Honig PK, Wortham DC, Zamani K, Conner DP, Mullin JC, Cantilena LR. Terfenadine-ketoconazole interaction: pharmacokinetic and electrocardiographic consequences. JAMA. 1993;269:1513–1518.CrossRefGoogle Scholar

Copyright information

© Drug Information Association, Inc 1998

Authors and Affiliations

  • Peter K. Honig
    • 1
  • Louis R. Cantilena
    • 2
  • Kenneth S. Santone
    • 3
  1. 1.Center for Drug Evaluation and ResearchUnited States Food and Drug AdministrationRockvilleUSA
  2. 2.Division of Clinical PharmacologyUniformed Services University of the Health SciencesBethesdaUSA
  3. 3.Metabolism and PharmacokineticsBristol-Myers Squibb Pharmaceutical Research InstituteWallingfordUSA

Personalised recommendations